Discover why Wells Fargo's Series L preferred shares are a preferred investment choice with low call risk and potential for ...

The effects of a chemical that’s produced when water is treated for viruses and bacteria are unknown, but there's a clear ...

Additional packages of clonazepam, a prescription medication used to treat seizures and anxiety, mislabeled with the ...

We’re only 6 weeks away from 2025, which means that it’s time to check in again with Wall Street’s investment banks and ...

Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to develop ...

Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly ...

"Vydura is another option that can be used to treat migraines or, if taken daily, prevent them. Vydura, which needs to be ...

MicroStrategy completed a $3 billion zero-interest convertible note offering while its stock fell 16.2% despite Bitcoin ...

Knightscope (KSCP) announces that it is proposing to offer and sell, subject to market conditions, shares of its Class A common stock in an ...

CV Sciences has agreed to acquire fellow CBD products maker Extract Labs for $1 million in newly issued common stock and $400,000 in cash. The San Diego-based company said Thursday that the ...

As of November 15, 2024, eGain has repurchased approximately $27.6 million of shares of its common stock under its stock repurchase program, leaving approximately $12.4 million of shares of its common ...

With nearly $3 billion in assets under management, including pending acquisitions, Abacus is the only publicly traded global alternative asset manager focused on lifespan-based financial products.